Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Zhu'an Ou"'
Autor:
Yong Tang, Yadan Li, Lei Zhang, Guihui Tong, Zhu'an Ou, Zhuocai Wang, Henghui Zhang, Guibin Qiao
Publikováno v:
Thoracic Cancer, Vol 11, Iss 4, Pp 1094-1098 (2020)
Abstract Anti‐programmed cell death 1 (PD‐1) and its ligand (PD‐L1) has emerged as a novel immunotherapy for non‐small cell lung cancer (NSCLC). However, the proportion of patients who may benefit from immunotherapy is limited and the factors
Externí odkaz:
https://doaj.org/article/96ffb34636e54fd9851ae07bae8dc0fd
Publikováno v:
Lung Cancer. 146:335-340
Objectives Primary pulmonary lymphoepithelioma-like carcinoma (LELC) is a rare subtype of non-small-cell lung cancer with no established treatment protocols. Immunotherapy is rarely used as a second-line choice in patients with advanced LELC, and mor
Publikováno v:
OncoTargets and Therapy. 12:2247-2258
Background Mouse double minute 2 (MDM2) contributes to cancer metastasis and epithelial-mesenchymal transition (EMT). This study aimed to investigate small mothers against decapentaplegic (Smad) signaling in MDM2-mediated EMT in lung adenocarcinoma (
Autor:
Haiping Xiao, Ming Liao, Yan Liu, Kai Su, Zhuohua Zhang, Enwu Xu, Xiufan Peng, Zhu'an Ou, Yong Tang, Yiwen Xuan, Guibin Qiao
Publikováno v:
Journal of Thoracic Disease. 8:499-504
Background: Extended thymectomy is indicated for patients with myasthenia gravis (MG) when drug-resistance or dependence is seen. We have employed a technique for subcostal thoracoscopic extended thymectomy (STET) on patients with MG. Methods: Clinic
Autor:
Yong Tang, Qihang Zhu, Han Han‑Zhang, Guibin Qiao, Ye Wang, Zhu'an Ou, Junyi Ye, Mei Yang, Zhe He, Xianling Liu
Publikováno v:
Oncology letters. 18(2)
Personalized medicine is revolutionizing the diagnosis and treatment of cancer; however, for personalized medicine to be used accurately, patient information is essential to determine the appropriate diagnosis, prognosis and treatment. The detection
Publikováno v:
Medicine
Introduction: The PD-1 inhibitors have shown good response in the treatment for many types of malignant tumors, but as monotherapy for advanced esophageal squamous carcinoma, the objective response rate is low. Here we report a case of the patient wi
Autor:
Yong Tang, Zhu'an Ou, Zhifang Yao, Guibin Qiao, Tang, Yong, Ou, Zhu'an, Yao, Zhifang, Qiao, Guibin
Publikováno v:
Medicine; Oct2019, Vol. 98 Issue 40, p1-4, 4p